237 related articles for article (PubMed ID: 21242994)
1. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
[TBL] [Abstract][Full Text] [Related]
2. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
[TBL] [Abstract][Full Text] [Related]
3. PIDDosome-independent tumor suppression by Caspase-2.
Manzl C; Peintner L; Krumschnabel G; Bock F; Labi V; Drach M; Newbold A; Johnstone R; Villunger A
Cell Death Differ; 2012 Oct; 19(10):1722-32. PubMed ID: 22595758
[TBL] [Abstract][Full Text] [Related]
4. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy.
Ellis L; Bots M; Lindemann RK; Bolden JE; Newbold A; Cluse LA; Scott CL; Strasser A; Atadja P; Lowe SW; Johnstone RW
Blood; 2009 Jul; 114(2):380-93. PubMed ID: 19383971
[TBL] [Abstract][Full Text] [Related]
6. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.
Jang TH; Park HH
BMB Rep; 2013 Sep; 46(9):471-6. PubMed ID: 24064063
[TBL] [Abstract][Full Text] [Related]
7. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
Jeon YJ; Ko SM; Cho JH; Chae JI; Shim JH
Int J Mol Med; 2013 Oct; 32(4):860-6. PubMed ID: 23877235
[TBL] [Abstract][Full Text] [Related]
8. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
9. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome.
Taghiyev AF; Guseva NV; Glover RA; Rokhlin OW; Cohen MB
Cancer Biol Ther; 2006 Sep; 5(9):1199-205. PubMed ID: 17110788
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.
Sasaki D; Imaizumi Y; Hasegawa H; Osaka A; Tsukasaki K; Choi YL; Mano H; Marquez VE; Hayashi T; Yanagihara K; Moriwaki Y; Miyazaki Y; Kamihira S; Yamada Y
Haematologica; 2011 May; 96(5):712-9. PubMed ID: 21228036
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
Yan-Fang T; Zhi-Heng L; Li-Xiao X; Fang F; Jun L; Gang L; Lan C; Na-Na W; Xiao-Juan D; Li-Chao S; Wen-Li Z; Pei-Fang X; He Z; Guang-Hao S; Yan-Hong L; Yi-Ping L; Yun-Yun X; Hui-Ting Z; Yi W; Mei-Fang J; Lin L; Jian N; Shao-Yan H; Xue-Ming Z; Xing F; Jian W; Jian P
PLoS One; 2015; 10(7):e0126566. PubMed ID: 26176219
[TBL] [Abstract][Full Text] [Related]
12. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
[TBL] [Abstract][Full Text] [Related]
13. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
Ishikawa C; Senba M; Mori N
Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.
Wang G; Niu X; Zhang W; Caldwell JT; Edwards H; Chen W; Taub JW; Zhao L; Ge Y
Cancer Lett; 2015 Jan; 356(2 Pt B):656-68. PubMed ID: 25458954
[TBL] [Abstract][Full Text] [Related]
15. PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
Heikaus S; Pejin I; Gabbert HE; Ramp U; Mahotka C
Cell Oncol; 2010; 32(1-2):29-42. PubMed ID: 20208132
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
Gupta M; Ansell SM; Novak AJ; Kumar S; Kaufmann SH; Witzig TE
Blood; 2009 Oct; 114(14):2926-35. PubMed ID: 19641186
[TBL] [Abstract][Full Text] [Related]
17. The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.
Peintner L; Dorstyn L; Kumar S; Aneichyk T; Villunger A; Manzl C
Cell Death Differ; 2015 Nov; 22(11):1803-11. PubMed ID: 25857265
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.
Nadella MV; Dirksen WP; Nadella KS; Shu S; Cheng AS; Morgenstern JA; Richard V; Fernandez SA; Huang TH; Guttridge D; Rosol TJ
Leukemia; 2007 Aug; 21(8):1752-62. PubMed ID: 17554373
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).
Kubo M; Kanaya N; Petrossian K; Ye J; Warden C; Liu Z; Nishimura R; Osako T; Okido M; Shimada K; Takahashi M; Chu P; Yuan YC; Chen S
Breast Cancer Res Treat; 2013 Jan; 137(1):93-107. PubMed ID: 23160924
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
Klein JM; Henke A; Sauer M; Bessler M; Reiners KS; Engert A; Hansen HP; von Strandmann EP
PLoS One; 2013; 8(11):e79502. PubMed ID: 24278143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
